Evidence map›Paper›PMID 30514371›Full record

ArticleBMC oral health2018

Characterization of the apical bridge barrier formed following amelogenin apexification.

Maha M F Mounir, Jamila M A Farsi, Turki Y Alhazzazi, Moustafa A Matar, Azza A El-Housseiny

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC oral health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maha M F MounirDepartment of Diagnostic Oral Sciences, King Abdulaziz University, Faculty of Dentistry, Jeddah, Saudi Arabia. maha.f.mounir@gmail.com.ORCID 0000-0002-5338-0428
Jamila M A FarsiDepartment of Oral Biology, King Abdulaziz University, Faculty of Dentistry, Jeddah, Saudi Arabia.
Turki Y AlhazzaziDepartment of Oral Biology, King Abdulaziz University, Faculty of Dentistry, Jeddah, Saudi Arabia.
Moustafa A MatarDepartment of Pediatric Dentistry, Faculty of Dentistry, Pharos University, Alexandria, Egypt.
Azza A El-HousseinyPediatric Dentistry Department, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
King Abdulaziz University · SAPharos University in Alexandria · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecombinant amelogenin protein (RAP) is reported to induce complete root apex formation in dog model when used as apexification therapy. It also induces pulp regeneration in 85% of the treated group. Thus, the aim of this study was to investigate the nature of the remaining regenerated calcified tissues of the RAP group that showed no pulp regeneration compared to the calcium hydroxide treated group (CH).

methodsA total of 240 dogs' open apex root canals were used, after establishment of canals contamination. Canals were cleaned, irrigated, and filled with RAP as an apexification material and compared with CH. Treated teeth were assessed by H&E, trichrome staining, and/or immunohistochemistry technique, at 1, 3, and 6 months.

resultsA time-dependent increase in the calcified tissue barrier was observed in the apex of the RAP-treated group compared to the CH-treated group. The newly formed dentin in this RAP group was mainly tubular dentin and was functionally attached to the bone by periodontal ligament, while the CH group showed dentin-associated mineralized tissue (DAMT) associated with the newly formed apical barrier.

conclusionsOut results suggest that RAP can be used as novel apexification material, resulting in a thickening and strengthening of the canal walls, and achieving apical closure.

Indexed as

AmelogeninAnimalsApexificationCalcium HydroxideDental PulpDental Pulp CavityDental Pulp NecrosisDentinDogsModels, AnimalOdontoblastsPeriodontal LigamentRecombinant ProteinsRegenerationRoot Canal Filling MaterialsTooth ApexAmelogeninCalcium HydroxideRecombinant ProteinsRoot Canal Filling MaterialsApexificationImmature teethNon-vital teethOpen apexR-amelogeninRAPRecombinant amelogeninRegenerationRoot canal therapy

Identifiers

PMID30514371
PMCPMC6280449
OpenAlexW2903431422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.